SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-092735
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:10
Documents
13
Period of Report
2024-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvmd-20240805.htm   iXBRL 8-K 47620
2 EX-99.1 rvmd-ex99_1.htm EX-99.1 187913
3 GRAPHIC img162218922_0.jpg GRAPHIC 83232
  Complete submission text file 0000950170-24-092735.txt   511565

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20240805.xsd EX-101.SCH 44920
15 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20240805_htm.xml XML 6434
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 241183545
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)